Related Experiment Videos
Aberrations of the G1- and G1/S-regulating genes in human cancer
J Bartkova1, J Lukas, J Bartek
1Department of Cell Cycle and Cancer, Danish Cancer Society, Copenhagen, Denmark.
Abstract:
Deregulated cell proliferation is the hallmark of cancer, and convergent data from the fields of cell-cycle research and molecular oncology have revealed the key role played by abnormalities of the cell-cycle control genes in multistep tumorigenesis. Along with the p53-mediated DNA damage checkpoint, the G1-governing pathway of D-type cyclins, their partner cyclin-dependent kinases (Cdk), Cdk inhibitors, and the retinoblastoma protein constitute a functional unit and prominent oncogenic target. We have learned a great deal about the molecular basis of G1 phase progression and G1/S transition, their proto-oncogenic defects, and potential clinical significance including diagnostic and prognostic applications and new approaches to gene therapy of cancer.
Insights
Cancer involves uncontrolled cell proliferation, often due to cell-cycle control gene defects. Understanding the G1 phase pathway is crucial for cancer diagnosis, prognosis, and gene therapy.
Area of Science:
- Molecular Oncology
- Cell-Cycle Research
Background:
- Deregulated cell proliferation is a key characteristic of cancer.
- Cell-cycle control genes play a critical role in multistep tumorigenesis.
Purpose of the Study:
- To elucidate the molecular basis of G1 phase progression and G1/S transition in cancer.
- To highlight the role of proto-oncogenic defects in these pathways.
- To discuss the clinical significance of these findings for cancer therapy.
Main Methods:
- Review of convergent data from cell-cycle research and molecular oncology.
- Analysis of the G1-governing pathway involving D-type cyclins, cyclin-dependent kinases (Cdks), Cdk inhibitors, and the retinoblastoma protein.
- Examination of the p53-mediated DNA damage checkpoint.
Main Results:
- Abnormalities in cell-cycle control genes are central to cancer development.
- The G1 pathway, including D-type cyclins, Cdks, inhibitors, and retinoblastoma protein, is a significant oncogenic target.
- The p53-mediated DNA damage checkpoint is integral to cell-cycle control.
Conclusions:
- Significant progress has been made in understanding G1 phase regulation and its defects in cancer.
- These insights have potential diagnostic and prognostic applications.
- New gene therapy strategies for cancer can be developed based on this knowledge.